cd4 pb Search Results


anti-cd4pb  (Becton Dickinson)
90
Becton Dickinson anti-cd4pb
Anti Cd4pb, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-cd4pb/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
anti-cd4pb - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
pb:cd4 pm4–5  (Becton Dickinson)
90
Becton Dickinson pb:cd4 pm4–5
Cancer septic mice had an increase in the absolute number of <t>CD4+</t> T cells 24 hours after CLP compared to previously healthy mice (A, p=0.0006) associated with decreased Annexin+7AAD+ CD4+ apoptotic cells (B, p=0.0006). This was not associated with a change in activation as measured by the percentage of CD25+ CD4+ (C, p=0.10) or CD69+ CD4+ cells (D, p=0.87). Cancer septic mice also had an increase in the absolute number of CD8+ T cells (E, p=0.002) without a statistically significant change in Annexin+7AAD+ CD8+ apoptotic cells (F, p=0.31). Activation was decreased in CD8+ cells in cancer septic mice as measured by the percentage of CD25+ (G, p=0.0006) or CD69+ cells (H, p=0.05), n=7 for all groups except n=6 for cancer septic CD69.
Pb:Cd4 Pm4–5, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pb:cd4 pm4–5/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
pb:cd4 pm4–5 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Cancer septic mice had an increase in the absolute number of CD4+ T cells 24 hours after CLP compared to previously healthy mice (A, p=0.0006) associated with decreased Annexin+7AAD+ CD4+ apoptotic cells (B, p=0.0006). This was not associated with a change in activation as measured by the percentage of CD25+ CD4+ (C, p=0.10) or CD69+ CD4+ cells (D, p=0.87). Cancer septic mice also had an increase in the absolute number of CD8+ T cells (E, p=0.002) without a statistically significant change in Annexin+7AAD+ CD8+ apoptotic cells (F, p=0.31). Activation was decreased in CD8+ cells in cancer septic mice as measured by the percentage of CD25+ (G, p=0.0006) or CD69+ cells (H, p=0.05), n=7 for all groups except n=6 for cancer septic CD69.

Journal: Shock (Augusta, Ga.)

Article Title: Murine pancreatic cancer alters T cell activation and apoptosis and worsens survival after cecal ligation and puncture

doi: 10.1097/SHK.0000000000001203

Figure Lengend Snippet: Cancer septic mice had an increase in the absolute number of CD4+ T cells 24 hours after CLP compared to previously healthy mice (A, p=0.0006) associated with decreased Annexin+7AAD+ CD4+ apoptotic cells (B, p=0.0006). This was not associated with a change in activation as measured by the percentage of CD25+ CD4+ (C, p=0.10) or CD69+ CD4+ cells (D, p=0.87). Cancer septic mice also had an increase in the absolute number of CD8+ T cells (E, p=0.002) without a statistically significant change in Annexin+7AAD+ CD8+ apoptotic cells (F, p=0.31). Activation was decreased in CD8+ cells in cancer septic mice as measured by the percentage of CD25+ (G, p=0.0006) or CD69+ cells (H, p=0.05), n=7 for all groups except n=6 for cancer septic CD69.

Article Snippet: Two panels were used: Panel 1 - FITC:CD25 (Clone: PC61, BD Pharmingen, San Jose, CA), PE:CD69 (Clone: H.2F3, Biolegend, San Diego, CA), PB:CD4 (Clone: PM4–5, BD Pharmingen), PO:CD8 (Clone: 53-6.7, Thermo Fisher), APC-Cy7:CD3 (Clone: 17A2, Biolegend); Panel 2 - FITC:Annexin V (Biolegend), PE:empty, PerCP:7-AAD (Biolegend), PB:CD4 (Clone: RPA-T4, BD Pharmingen), PO:CD8 (Clone 53-6.7, Thermo Fisher), AF700:CD3 (Clone 500A2, eBioscience).

Techniques: Activation Assay

CD4+ activation was similar in the blood between cancer septic mice and previously healthy septic mice as measured by CD25+ (A, p=0.28) and CD69+ (B, p=0.43) cells. Similarly blood CD8+ activation was similar in the blood as measured by CD25+ (C, p=0.63) and CD69+ (D, p=0.43) cells. CD4+CD25+ cells were similar in the mesenteric lymph nodes between cancer septic mice and previously healthy septic mice (E, p=0.87) although CD4+CD69+ cells were higher in cancer/septic mice (F, p=0.02). No difference was detected in activation of CD8+ cells in the mesenteric lymph nodes whether measured by CD25+ (G, p=0.82) or CD69+ (H, p=0.43) cells, n=6–8/group for all panels.

Journal: Shock (Augusta, Ga.)

Article Title: Murine pancreatic cancer alters T cell activation and apoptosis and worsens survival after cecal ligation and puncture

doi: 10.1097/SHK.0000000000001203

Figure Lengend Snippet: CD4+ activation was similar in the blood between cancer septic mice and previously healthy septic mice as measured by CD25+ (A, p=0.28) and CD69+ (B, p=0.43) cells. Similarly blood CD8+ activation was similar in the blood as measured by CD25+ (C, p=0.63) and CD69+ (D, p=0.43) cells. CD4+CD25+ cells were similar in the mesenteric lymph nodes between cancer septic mice and previously healthy septic mice (E, p=0.87) although CD4+CD69+ cells were higher in cancer/septic mice (F, p=0.02). No difference was detected in activation of CD8+ cells in the mesenteric lymph nodes whether measured by CD25+ (G, p=0.82) or CD69+ (H, p=0.43) cells, n=6–8/group for all panels.

Article Snippet: Two panels were used: Panel 1 - FITC:CD25 (Clone: PC61, BD Pharmingen, San Jose, CA), PE:CD69 (Clone: H.2F3, Biolegend, San Diego, CA), PB:CD4 (Clone: PM4–5, BD Pharmingen), PO:CD8 (Clone: 53-6.7, Thermo Fisher), APC-Cy7:CD3 (Clone: 17A2, Biolegend); Panel 2 - FITC:Annexin V (Biolegend), PE:empty, PerCP:7-AAD (Biolegend), PB:CD4 (Clone: RPA-T4, BD Pharmingen), PO:CD8 (Clone 53-6.7, Thermo Fisher), AF700:CD3 (Clone 500A2, eBioscience).

Techniques: Activation Assay

No differences were noted between cancer septic mice and previously healthy septic mice in CD4+ apoptosis (A, p=0.99), CD8+ apoptosis (B, p=0.87), or gut apoptosis as measured by H&E (C, p=0.58) or active caspase 3 (D, p=0.73). No differences were noted in renal function as measured by BUN (E, p=0.37) or Cr (F, p=0.21), n=9 for all groups.

Journal: Shock (Augusta, Ga.)

Article Title: Murine pancreatic cancer alters T cell activation and apoptosis and worsens survival after cecal ligation and puncture

doi: 10.1097/SHK.0000000000001203

Figure Lengend Snippet: No differences were noted between cancer septic mice and previously healthy septic mice in CD4+ apoptosis (A, p=0.99), CD8+ apoptosis (B, p=0.87), or gut apoptosis as measured by H&E (C, p=0.58) or active caspase 3 (D, p=0.73). No differences were noted in renal function as measured by BUN (E, p=0.37) or Cr (F, p=0.21), n=9 for all groups.

Article Snippet: Two panels were used: Panel 1 - FITC:CD25 (Clone: PC61, BD Pharmingen, San Jose, CA), PE:CD69 (Clone: H.2F3, Biolegend, San Diego, CA), PB:CD4 (Clone: PM4–5, BD Pharmingen), PO:CD8 (Clone: 53-6.7, Thermo Fisher), APC-Cy7:CD3 (Clone: 17A2, Biolegend); Panel 2 - FITC:Annexin V (Biolegend), PE:empty, PerCP:7-AAD (Biolegend), PB:CD4 (Clone: RPA-T4, BD Pharmingen), PO:CD8 (Clone 53-6.7, Thermo Fisher), AF700:CD3 (Clone 500A2, eBioscience).

Techniques: